Body Mass Trajectory Affects the Long-Term Occurrence of Metabolic Syndrome in Adult Patients with Severe Obesity
Author:
Hazart JulietteORCID, Montel Florence, Gentes Elodie, Lahaye ClémentORCID, Pouget MélanieORCID, Farigon Nicolas, Miolanne Magalie, Mulliez AurélienORCID, Boirie YvesORCID
Abstract
Independently of absolute BMI values, the amount, onset date, and duration of early body weight gain may influence cardio-metabolic health later in adulthood. Values of cardiac and metabolic variables from a cohort study of morbidly obese patients were retrospectively analyzed to study the association between early weight history and metabolic syndrome (MetS) occurrence in adults. Of 950 patients with severe morbid obesity (age 44.3 ± 13.8 y, BMI 42.5 ± 7.0 kg/m2), 31.4% had started excess weight gain in childhood (CH), 19.9% in adolescence (ADO), and 48.7% in adulthood (AD). Despite different BMI values, MetS prevalence (57.8%) was not significantly different in the three groups (54.4% CH vs. 57.7% ADO vs. 59.8% AD, p = 0.59). The overweight onset period was not significantly associated with the development of MetS in adults (ADO: OR = 1.14 [0.69–1.92], p = 0.60; AD: OR = 0.99 [0.62–1.56], p = 0.95) despite a higher BMI in the early obesity onset group. Weight gain of more than 50% after age 18 years significantly increased the risk of MetS (OR = 1.75 [1.07–2.88], p = 0.026). In addition to crude BMI values, analysis of body mass trajectories is a relevant clinical tool in the assessment of metabolic risk, suggesting that the magnitude of weight gain may be more important for metabolic syndrome progression than the period of obesity onset.
Subject
Pediatrics, Perinatology and Child Health
Reference28 articles.
1. The GBD 2013 Obesity Collaboration, Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E., Biryukov, S., and Abbafati, C. (2014). Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet, 384, 766–781. 2. GBD 2015 Obesity Collaborators, Afshin, A., Forouzanfar, M.H., Reitsma, M.B., Sur, P., Estep, K., Lee, A., Marczak, L., Mokdad, A.H., and Moradi-Lakeh, M. (2017). Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N. Engl. J. Med., 377, 13–27. 3. Corpulence des enfants et des adultes en France métropolitaine en 2015. Résultats de l’étude Esteban et évolution depuis 2006;Verdot;Bull. Epidémiol. Hebd.,2017 4. Obesity, Metabolic Syndrome, and Cardiovascular Disease;Grundy;J. Clin. Endocrinol. Metab.,2004 5. Global BMI Mortality Collaboration, Di Angelantonio, E., Bhupathiraju, S., Wormser, D., Gao, P., Kaptoge, S., de Gonzalez, A.B., Cairns, B., Huxley, R., and Jackson, C. (2016). Body-mass index and all-cause mortality: Individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet, 388, 776–786.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|